Pharmaceutical heterogeneous systems. 3. Inhibition of stearate lubricant induced degradation of aspirin by the use of certain organic acids.
D000812:Anhydrides; D001241:Aspirin / Q000032:analysis*; D002214:Capsules; D003510:Cyclohexanes; D004355:Drug Stability; D006863:Hydrogen-Ion Concentration; D008274:Magnesium; D008293:Malates; D008298:Maleates; D012459:Salicylates; D013053:Spectrophotometry; D013229:Stearic Acids; D013644:Tartrates
D000812:Anhydrides; D002214:Capsules; D003510:Cyclohexanes; D008293:Malates; D008298:Maleates; D012459:Salicylates; D013229:Stearic Acids; D013644:Tartrates; D008274:Magnesium; D001241:Aspirin